Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Suspended 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 7Gastrointestinal 7Breast 6Gynecologic 3CNS 3Thoracic 2Plasma cell 2Other 2Lymphoid 2Dermatologic 2Other solid neoplasm 1Other hematologic neoplasm 1

Conditions

Glioblastoma 2Glioma 1Brain Neoplasms 1

Interventions

Temozolomide 165Magnetic Resonance Spectroscopy 130Radiotherapy 95Specimen Handling 80Radiosurgery 60Cyclophosphamide 55pembrolizumab 51Bevacizumab 51Nivolumab 48Radiation 47Carboplatin 34Biopsy 33Irinotecan 29Lomustine 25Etoposide 25Vincristine 23Topotecan 23Ipilimumab 23dinutuximab 21Cisplatin 21Blood Specimen Collection 21fludarabine 19Radiotherapy, Intensity-Modulated 19X-Rays 18Surgical Procedures, Operative 18abemaciclib 16Mental Status and Dementia Tests 16Granulocyte-Macrophage Colony-Stimulating Factor 16Pemetrexed 15atezolizumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Diet Therapy × CNS × 1 year × Clear all
NCT07091864 2026-05-07

Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma

Mayo Clinic

Phase NA Recruiting
116 enrolled
CNS

Glioblastoma

NCT02286167 2026-03-24

GLAD

Wake Forest University Health Sciences

Phase NA Completed
25 enrolled
CNS

Glioblastoma, Glioma

NCT05428852 2026-02-10

Keto-Brain:Investigating the Use of Ketogenic Diets in Brain Metastases

Ohio State University Comprehensive Cancer Center

Phase NA Suspended
24 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡